Alternatives to Prevymis If You Can't Fill Your Prescription

Prevymis (letermovir) is a first-in-class antiviral that has changed CMV prophylaxis for transplant patients. But what if you can't get your prescription filled — whether due to availability, cost, or insurance issues? This guide covers the available alternatives to Prevymis and what you need to know before switching.

Important: Never switch or stop your CMV prophylaxis without first consulting your transplant physician or infectious disease specialist. CMV infection in immunocompromised patients can be life-threatening. The alternatives below all carry different risk profiles and require medical supervision.

Why Prevymis Is Often Preferred

Before discussing alternatives, it's worth understanding why Prevymis was prescribed in the first place. Prevymis works through a novel mechanism — inhibiting the CMV DNA terminase complex — that is completely different from older antivirals like ganciclovir. This means it has no cross-resistance with ganciclovir or valganciclovir, and it causes significantly fewer bone marrow side effects, particularly leukopenia (low white blood cell counts). A phase 3 trial found that letermovir recipients had leukopenia or neutropenia rates of 26% compared to 64% in the valganciclovir group.

Alternative 1: Valganciclovir (Valcyte)

Valganciclovir is the most commonly used alternative to Prevymis and the longstanding standard of care for CMV prophylaxis in high-risk kidney transplant recipients before letermovir was available. It is an oral prodrug of ganciclovir, meaning the body converts it to ganciclovir after absorption.

Advantages: Generic available (much lower cost); widely stocked at pharmacies; once-daily oral dosing; proven effectiveness

Disadvantages: Significant bone marrow suppression (leukopenia, neutropenia, thrombocytopenia); dose must be adjusted based on kidney function; requires more frequent blood monitoring; not recommended for patients with severe renal impairment without dose adjustment

Standard dose: 900 mg once daily for up to 200 days post-kidney transplant or 100 days post-HSCT. Dose reduction required if creatinine clearance is below 60 mL/min.

Alternative 2: Ganciclovir (IV)

Ganciclovir is the original antiviral for CMV and the parent compound of valganciclovir. It is administered intravenously, making it appropriate for hospitalized patients or those who cannot take oral medications. Prevymis was actually designed partly to overcome the toxicity limitations of ganciclovir.

Advantages: Effective for CMV treatment and prophylaxis; IV option for patients who cannot take oral medications; generic available

Disadvantages: Requires IV infusion (not suitable for outpatient prophylaxis); significant bone marrow toxicity; nephrotoxicity; more burdensome than oral options

Alternative 3: High-Dose Acyclovir or Valacyclovir

High-dose acyclovir or its oral prodrug valacyclovir have historically been used as lower-toxicity alternatives in HSCT settings, though they are less potent against CMV than ganciclovir-class drugs or letermovir. They are less myelosuppressive than ganciclovir, but clinical studies have shown inferior efficacy for CMV prophylaxis.

Advantages: Much lower cost; minimal bone marrow suppression; widely available

Disadvantages: Less effective CMV prophylaxis than ganciclovir-class or letermovir; generally considered inferior options unless specific circumstances apply

Alternative 4: Foscarnet (Reserved for Special Cases)

Foscarnet is an IV antiviral typically reserved for CMV that is resistant to ganciclovir, or for patients who cannot tolerate ganciclovir. It is not used for routine CMV prophylaxis due to its significant side effects — primarily severe nephrotoxicity (kidney damage). It is generally a last-resort option.

How to Talk to Your Doctor About Alternatives

If you cannot fill your Prevymis prescription, contact your transplant physician immediately. When you call, have this information ready:

• Your current CMV serostatus (R+ for HSCT; D+/R- for kidney transplant)
• How many days post-transplant you are (timing matters for which drugs are appropriate)
• Your current kidney function (creatinine clearance), as it affects valganciclovir dosing
• Whether you are on cyclosporine (relevant for Prevymis dosing and drug interactions)
• The specific reason you can't fill Prevymis (insurance issue, pharmacy stock, cost)

Before Switching, Try These Steps First

Switching from Prevymis to an alternative should be a last resort — not the first response to a difficulty filling the prescription. Before switching, try: contacting a national specialty pharmacy, using medfinder to search for Prevymis at pharmacies near you, or requesting urgent prior authorization through your transplant team. For a step-by-step guide, see: How to Find Prevymis in Stock Near You.